Cite
Biochemical Control and Toxicity Outcomes of Stereotactic Body Radiation Therapy Versus Low-Dose-Rate Brachytherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer.
MLA
Gogineni, Emile, et al. “Biochemical Control and Toxicity Outcomes of Stereotactic Body Radiation Therapy Versus Low-Dose-Rate Brachytherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer.” International Journal of Radiation Oncology, Biology, Physics, vol. 109, no. 5, Apr. 2021, pp. 1232–42. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2020.11.003.
APA
Gogineni, E., Rana, Z., Soberman, D., Sidiqi, B., D’Andrea, V., Lee, L., Potters, L., & Parashar, B. (2021). Biochemical Control and Toxicity Outcomes of Stereotactic Body Radiation Therapy Versus Low-Dose-Rate Brachytherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics, 109(5), 1232–1242. https://doi.org/10.1016/j.ijrobp.2020.11.003
Chicago
Gogineni, Emile, Zaker Rana, Danielle Soberman, Baho Sidiqi, Vincent D’Andrea, Lucille Lee, Louis Potters, and Bhupesh Parashar. 2021. “Biochemical Control and Toxicity Outcomes of Stereotactic Body Radiation Therapy Versus Low-Dose-Rate Brachytherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer.” International Journal of Radiation Oncology, Biology, Physics 109 (5): 1232–42. doi:10.1016/j.ijrobp.2020.11.003.